diabetes mellitus undergoing angioplasty. diabetes mellitus and ischemic heart disease
Conditions
Interventions
intervention group will recieve 1200 mg pentoxyfylline three times divided dose with standard treatments
control group will only recieve standard treatments.
Treatment - Drugs
intervention group will recieve 1200 mg pentoxyfylline three times divided dose with standard treatments
control group will only recieve standard treatments
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Ischemic heart diseases and diabetic patients; age 18-85; undergoing of angioplasty with stent insertion; filling of consent form. Exclusion Criteria: Elevation of CK-MB and cTnI before PCI; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; acute MI; cardiogenic shock; dialysis; pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cystatin c. Timepoint: 24 hours before and after. Method of measurement: elisa kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Creatinine. Timepoint: 24 hours before angioplasty and after. Method of measurement: elisa kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Taher Entezari-maleki
tabriz university of medical science
Outcome results
None listed